Capitol Hill Healthcare Update

by BakerHostetler
Contact

Graham, Cassidy Push Last-Ditch Effort on ACA Repeal

Republican senators pushing a last-ditch effort to overhaul the Affordable Care Act (ACA) say they are within one vote of having the support needed to pass their bill.

Sens. Bill Cassidy (R-La.) and Lindsey Graham (R-S.C.) said they would continue to push for a vote this month before the expiration of fast-track reconciliation legislation that allows Republicans to pass the bill on a party-line vote. The senators’ bill would repeal the ACA’s individual and employer mandate penalties and transform the law’s Medicaid expansion into a trillion-dollar block grant for states, mostly by redirecting funding from states that expanded their Medicaid programs to those that did not.

Although not all of the 52 Senate Republicans have publicly announced their position on the bill, Cassidy said he has 49 commitments to back his legislation. Republicans would need only one more vote before Vice President Mike Pence could cast the tie-breaking vote.

Sen. Rand Paul (R-Ky.) announced last week that he would oppose the bill, and Sen. Susan Collins (R-Maine) has expressed reservations because it would block Planned Parenthood from receiving federal reimbursements. Sen. John McCain (R-Ariz.), who brought down the GOP leadership’s last ACA repeal effort in July, declined to say how he would vote on Cassidy-Graham but said Sunday he preferred bipartisan legislation. Sen. Lisa Murkowski (R-Alaska) is a potential wildcard but shares Collins’ concern over Planned Parenthood funding.

The Congressional Budget Office (CBO) must produce a detailed economic analysis of the bill – including its cost and coverage impact – before a Senate vote. Majority Leader Mitch McConnell (R-Ky.) has called on the CBO to accelerate its score of the bill, but that process could take weeks to complete.

Another process hurdle facing Cassidy and Graham is that the filibuster-proof protection of the reconciliation legislation expires September 30. That means if the Senate approves the bill this month, the House would have to pass it without any changes for it to go to the White House for President Trump’s signature. Any House changes to the bill would trigger another Senate vote – and any Senate vote after September 30 would allow Democrats to block the bill with a filibuster.

One Republican Senate aide actively working on the bill said “everything would have to go right” for a Senate vote this month.

House Exploring Adding Other Health Items to CHIP Renewal

With Senate leaders agreeing to the outlines of a five-year reauthorization of the Children’s Health Insurance Program (CHIP), House Republicans are exploring whether legislation to renew the popular program can be used to carry other healthcare provisions.

Key House lawmakers are weighing whether to include repeal of the Independent Payment Advisory Board and suspension of the 2.3 percent excise tax on medical device manufacturers. Also under consideration is a host of mostly narrow bipartisan Medicare provisions advanced by the House Ways and Means Committee.

The House’s interest in a larger legislative package around CHIP does not guarantee it will occur. Senate Finance Committee staff say they would be open to a larger effort but want the House to propose specifics.

A larger CHIP legislative package also would likely increase its cost, with Energy and Commerce Committee staff saying they’re looking at an overall of cost of between $20 billion and $30 billion over 10 years. Potential offsetting pay-fors include extending the Medicare sequester and changes to the prescription drug Medicaid rebate for line extensions, or new formulations. Also discussed have been changes to the 340B prescription drug program, including a two-year moratorium on new entities joining the program and tightening certain program definitions.

House and Senate committee leaders want Congress to act before CHIP technically expires on September 30, but they acknowledge most states will have adequate funding to carry them into December if Congress fails to authorize CHIP this month.

ACA Stabilization Could Be Introduced This Week

Leaders on the Senate HELP Committee may introduce legislation as soon as this week to stabilize insurance premiums in the ACA’s individual markets.

The outlines of the agreement would extend the ACA’s cost-sharing reduction payments to insurers to subsidize premiums for individuals while also providing states with increased flexibility to approve coverage plans. The waiver details are not settled and Democrats warn they will object to waivers that allow states to undermine the ACA’s protections and coverage mandates.

Committee Chairman Lamar Alexander (R-TN) hopes to have a bill ready prior to this month’s deadline for insurers to finalize their 2018 plans, but that timing is uncertain.

While there is bipartisan support on the committee to extend the insurance payments, Republicans want greater state waiver flexibility than Democrats are likely to approve. Senate Finance Committee Chairman Orrin Hatch (R-Utah) is another hurdle to reaching agreement as his committee has jurisdiction over some of the policy Alexander would include in his legislation.

Hatch Wants Details on Elder Abuse in Nursing Homes

The Chairman of the Senate Finance Committee is questioning whether the U.S. Department of Health and Human Services (HHS) will take enforcement action after an independent report revealed widespread elder abuse in federally funded nursing homes.

HHS’s inspector general last month found injuries to 134 Medicare patients that may have been the result of abuse and neglect at long-term care facilities. Orrin Hatch (R-Utah) wrote to HHS Secretary Tom Price last week seeking more details and asking whether the department would change its procedures on reporting elder abuse or take enforcement actions.

The inspector general report found CMS is not enforcing a requirement that nursing homes notify employees of their obligation to report reasonable suspicions of a crime, including elder abuse.

Senate Trying To Pass Chronic Care Legislation

Senate leaders are gauging whether there is support to approve a package of chronic care legislation, including expanding Medicare’s coverage of telehealth services.

The bill, which won unanimous approval in May in the Senate Finance Committee, would make it easier for private Medicare plans and accountable care organizations to offer telemedicine services. It would also expand a current program for house calls for the elderly and allow for reimbursement of home dialysis treatment.

Senate leaders are trying to “hotline” the bill, which would allow approval by unanimous consent. Budget Committee Chairwoman Diane Black (R-Tenn.) has introduced a separate chronic care bill in the House.

Democrats Seek Details from CMS on Drug Reimbursement

A group of House Democrats is seeking information from the Centers for Medicare & Medicaid Services (CMS) on the agency’s agreement with Novartis for a “money-back guarantee” of the company’s newly approved CAR-T immunotherapy treatment.

When Novartis won FDA approval this month for its drug Kymriah to treat an aggressive form of leukemia in children, Novartis and CMS announced that the company would not receive reimbursement if a patient failed to respond to the treatment.

Rep. Lloyd Doggett (D-Texas) and several other House Democrats are asking CMS to reveal details of the agreement, including whether the federal government would pay the full $475,000 price of the treatment if a patient relapsed, the criteria used to evaluate a successful treatment and who ultimately would judge that criteria.

House Lawmaker Drafting Medical Device Cyber Bill

Draft legislation circulating in the House would establish a working group at the National Institute for Standards and Technology to recommend voluntary frameworks and guidelines to increase cybersecurity for medical devices. Rep. Dave Trott (R-Mich.) is drafting the House legislation but it is not clear when a bill will be introduced. Other medical device cyber legislation is under development in the Senate.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© BakerHostetler | Attorney Advertising

Written by:

BakerHostetler
Contact
more
less

BakerHostetler on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):
hide

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.

Security

JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.